City of Hope has so many breakthroughs in cancer, diabetes and HIV/AIDS - and so many stories - that we've tailored our blog, Breakthroughs, to provide something for every reader. Whether the breakthroughs are about medical research, treatment advances or personal triumphs, they're all connected.
November 16, 2017 | Katie Neith
Researchers have been searching for better islet transplant sites, but it’s been a challenge to find a superior option — until now.
November 10, 2017 | Katie Neith
A recent recruit to Beckman Research Institute of City of Hope has received a three-year grant from the St. Baldrick's Foundation to support his work on a vaccine for Kaposi sarcoma.
November 9, 2017 | City of Hope
Findings from a new study provide fresh insights into the treatment of women with metastatic breast cancer whose tumors are no longer responding to available treatments.
November 9, 2017 | By Katie Neith
City of Hope’s Defu Zeng, professor of diabetes immunology and hematopoietic cell transplantation and colleagues recently uncovered important information about the chronic GVHD.
November 3, 2017 | Wayne Lewis
According to a new paper in Stem Cells Translational Medicine, the authors identify the role of a nurse qualified in both patient care and research protocols, the so-called “hybrid nurse” — a homegrown City of Hope innovation — as an important component of their success in the development of the Alpha Clinic.
November 1, 2017 | Denise Heady
Say the words “brain tumor” and most people will likely think of cancer. But there’s reason for optimism - recent advances in screening and treatment, such as CAR-T cell therapy, mean patient outcomes and quality of life are continuing to improve.
October 25, 2017 | Abe Rosenberg
When Ming was first diagnosed with breast cancer, she knew she'd need surgery. But at her doctor's urging she also took an additional step, scheduling a session with a City of Hope genetic counselor.
October 18, 2017 | City of Hope
City of Hope will be the one of the first authorized centers in the nation to provide axicabtagene ciloleucel, which the U.S. Food and Drug Administration (FDA) announced today is the first approved CAR-T therapy for adult patients who have not responded to or who have relapsed after at least two other kinds of treatment.
October 18, 2017 | Saundra Young
A new book, “Detecting & Living with Breast Cancer For Dummies,” from City of Hope researcher Kimlin Tam Ashing, Ph.D., offers women sound advice on managing breast cancer.
July 24, 2017 | Denise Heady
A study led by City of Hope neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., offers novel insights on how cancer cells in HER2-positive breast cancer develop the ability to break through the blood-brain barrier and, ultimately, how they can be stopped.
Load MoreBack To Top